VVOS Vivos Therapeutics, Inc. Common Stock SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Best Medical Devices Stocks 2026 →

Vivos Therapeutics (VVOS) Stock: Buy, Sell, or Hold?

$0.05
0.00 (-5.10%) ▼
5d: -44.9% 30d: -59.25% 90d: -80.49%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
37/100
Position
OVERSOLD
30-Day Fair Range
$0.09 – $0.14
Position: OVERSOLD
Forward P/E & Valuation
-0.1x
Next 12M consensus est.
Wall Street Target
$1.93
+3464.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.05 / $0.10
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: VVOS is down 44.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When VVOS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: VVOS is currently trading at $0.05, which is considered oversold relative to its 30-day fair value range of $0.09 to $0.14.

Technical Outlook: Technically, VVOS is in a strong downtrend. Immediate support is located at $0.05, while resistance sits at $0.10. Short-term momentum is weak, with the stock down 5.1% recently.

Market Sentiment: VVOS scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.93 (+3464.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $0.09 - $0.14
Company Quality Score 37/100 (SELL)
Volume Confirmation HIGH
Confidence Score 52.6%

Trading Range & Key Levels

30-Day Trading Range $0.09 - $0.14
Current vs Trading Range OVERSOLD
Support Level $0.05
Resistance Level $0.10
Current Trend Strong Downtrend
Technical data as of Nov 20, 2026

Institutional Signals, 13F Whale Activity & Setup Structure

Quantitative Research Feed
Phase & Gamma Walls BREAKDOWN
Days in Phase: 113d (50% conf)

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-5.1%)
  • BULLISH: Trading 3464.8% below Wall St target ($1.93)
  • WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -0.07
Wall Street Target $1.93 (+3464.8%)
Revenue Growth (YoY) 34.9%
Profit Margin -121.8%
Share VVOS Analysis

Share this live VVOS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (VVOS)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
Retail Stream Volume
1 msgs
24h retail stream
Last Tracked
Nov 17, 2026
Daily AI digest
AI Retail Discussion Summary: Vivos Therapeutics reported a 24% increase in revenue for Q3 2026, with a reduced operating loss and cost savings. The company regained compliance with Nasdaq's stockholders' equity requirement.
Key Retail Themes: Financial improvement Cost reduction
Aggregated from r/wallstreetbets, r/stocks & retail trader streams. View All Trending Reddit & WSB Stocks →
Last updated: November 22, 2026 5:57 AM ET
Data refreshes hourly during market hours. Next update: 6:57 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for VVOS.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
DXCM
DexCom Inc
STRONG BUY
29 analysts
$99 51 HOLD
EW
Edwards Lifesciences Corp
STRONG BUY
30 analysts
$113 44 HOLD
ABT
Abbott Laboratories
STRONG BUY
28 analysts
$119 47 HOLD
SYK
Stryker Corporation
STRONG BUY
30 analysts
$339 43 HOLD
BSX
Boston Scientific Corp
BUY
31 analysts
$50 54 HOLD
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals